...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Studies on the formation of polymeric nano-emulsions obtained via low-energy emulsification and their use as templates for drug delivery nanoparticle dispersions
【24h】

Studies on the formation of polymeric nano-emulsions obtained via low-energy emulsification and their use as templates for drug delivery nanoparticle dispersions

机译:通过低能乳化获得的聚合物纳米乳液的形成及其作为药物递送纳米颗粒分散体的模板的研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ethylcellulose nanoparticles have been obtained from O/W nano-emulsions of the water/polyoxyethylene 10 oleyl ether/[ethylacetate + 4 wt% ethylcellulose] system by low energy-energy emulsification at 25 degrees C. Nano-emulsions with droplet sizes below 200nm and high kinetic stability were chosen for solubilising dexamethasone (DXM). Phase behaviour, conductivity and optical analysis studies of the system have evidenced for the first time that both, the polymer and the drug play a role on the structure of the aggregates formed along the emulsification path. Nano-emulsion formation may take place by both, phase inversion and self-emulsification. Spherical polymeric nanoparticles containing surfactant, showing sizes below 160 nm have been obtained from the nano-emulsions by organic solvent evaporation. DXM loading in the nanoparticles was high (>90%). The release kinetics of nanoparticle dispersions with similar particle size and encapsulated DXM but different polymer to surfactant ratio were studied and compared to an aqueous DXM solution. Drug release from the nanoparticle dispersions was slower than from the aqueous solution. While the DXM solution showed a Fickian release pattern, the release behaviour from the nanoparticle dispersions was faster than that expected from a pure Fickian release. A coupled diffusion/relaxation model fitted the results very well, suggesting that polymer chains undergo conformational changes enhancing drug release. The contribution of diffusion and relaxation to drug transport in the nanoparticle dispersions depended on their composition and release time. Surfactant micelles present in the nanoparticle dispersion may exert a mild reservoir effect. The small particle size and the prolonged DXM release provided by the ethylcellulose nanoparticle dispersions make them suitable vehicles for controlled drug delivery applications. (C) 2016 Elsevier B.V. All rights reserved.
机译:通过水/聚氧乙烯10油基醚/ [乙酸乙酯+ 4 wt%乙基纤维素]体系的O / W纳米乳液,通过在25摄氏度下的低能能量乳化获得了乙基纤维素纳米颗粒。液滴尺寸小于200nm的纳米乳液和选择高动力学稳定性来溶解地塞米松(DXM)。该系统的相行为,电导率和光学分析研究首次证明,聚合物和药物都对沿乳化路径形成的聚集体的结构起作用。纳米乳液的形成可以通过相转化和自乳化两者来进行。通过有机溶剂蒸发从纳米乳液中获得了尺寸小于160nm的含有表面活性剂的球形聚合物纳米颗粒。纳米颗粒中的DXM负载很高(> 90%)。研究了具有相似粒径和封装DXM但聚合物与表面活性剂比率不同的纳米粒子分散体的释放动力学,并将其与DXM水溶液进行了比较。从纳米颗粒分散体释放的药物比从水溶液中释放的药物要慢。尽管DXM解决方案显示了Fickian释放模式,但纳米颗粒分散体的释放行为比纯Fickian释放的预期行为要快。耦合的扩散/松弛模型很好地拟合了结果,表明聚合物链发生构象变化,从而增强了药物释放。纳米颗粒分散体中扩散和弛豫对药物运输的贡献取决于其组成和释放时间。存在于纳米颗粒分散体中的表面活性剂胶束可以发挥适度的储库作用。乙基纤维素纳米颗粒分散体提供的小粒径和DXM的延长释放使其成为控制药物输送应用的合适载体。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号